Hemostasis Today

April, 2026
April 2026
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
27282930  
Hassan Raza: A Smarter Risk Prediction in MPNs Using AI
Apr 23, 2026, 07:50

Hassan Raza: A Smarter Risk Prediction in MPNs Using AI

Hassan Raza, Consultant Hematologist and Transfusion Medicine Specialist, shared on LinkedIn about a recent article by Xuezi Hu et al, published in Blood, adding:

”AI Enhancing Risk Prediction in MPNs

A recent American Society of Hematology (Blood 2025) study introduces MEAM – an AI model analyzing bone marrow morphology in ET and PV.

What it does:

Predicts multiple outcomes:
• Thrombosis/bleeding
• Myelofibrosis progression
• AML transformation
• Overall survival

Why it stands out:

Matches or exceeds traditional models (IPSET, R-IPSET-T)

Improves prediction when combined with clinical scores

Detects high-risk patients missed by conventional tools, especially younger patients

Clinical relevance:
Moves morphology from subjective assessment to a quantifiable, dynamic prognostic tool

Takeaway:
AI-integrated morphology may significantly refine risk stratification and treatment decisions in MPNs.”

Title: Multi-endpoint AI morphology model (MEAM) enhances risk prediction for vascular events and disease progression in MPNs

Authors: Xuezi Hu, Alan Aberdeen, Sharon Ruane, Rosalin Cooper, Timothy Ebsworth, Sanam Loghavi, David Ross, Diana Iarossi, Markus Tiemann, Amin Turki, Andrew Sung, Mingyi Chen, Zijun Xu-Monette, Ken Young, Anna Godfrey, Jyoti Nangalia, Joanna Baxter, Anthony Green, Mary Frances McMullin, Adam Mead, Claire Harrison, Jens Rittscher, Korsuk Sirinukunwattana, Daniel Royston

Hassan Raza: A Smarter Risk Prediction in MPNs Using AI

Stay updated on all scientific advances with Hemostasis Today.